733 related articles for article (PubMed ID: 16091128)
21. AML-loaded DC generate Th1-type cellular immune responses in vitro.
Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ
Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
23. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
24. Immediate exposure to TNF-alpha activate dendritic cells derived from non-purified cord blood mononuclear cells.
Ebrahimi M; Hassan ZM; Hadjati J; Hayat P; Moazzeni SM
Iran J Immunol; 2009 Sep; 6(3):107-18. PubMed ID: 19801784
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
26. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
27. Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells.
Bai L; Feuerer M; Beckhove P; Umansky V; Schirrmacher V
Int J Oncol; 2002 Feb; 20(2):247-53. PubMed ID: 11788884
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM
Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033
[TBL] [Abstract][Full Text] [Related]
30. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
31. Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts.
Gong J; Koido S; Kato Y; Tanaka Y; Chen D; Jonas A; Galinsky I; DeAngelo D; Avigan D; Kufe D; Stone R
Leuk Res; 2004 Dec; 28(12):1303-12. PubMed ID: 15475072
[TBL] [Abstract][Full Text] [Related]
32. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
33. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells.
Czerniecki BJ; Carter C; Rivoltini L; Koski GK; Kim HI; Weng DE; Roros JG; Hijazi YM; Xu S; Rosenberg SA; Cohen PA
J Immunol; 1997 Oct; 159(8):3823-37. PubMed ID: 9378970
[TBL] [Abstract][Full Text] [Related]
34. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
[TBL] [Abstract][Full Text] [Related]
35. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
Lee JJ; Choi BH; Nam JH; Park MS; Song WH; Yang DH; Kim YK; Cho SH; Chung IJ; Park KS; Lee IK; Kim HJ
J Clin Apher; 2004; 19(3):130-6. PubMed ID: 15493054
[TBL] [Abstract][Full Text] [Related]
36. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
[TBL] [Abstract][Full Text] [Related]
38. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
39. Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
Houtenbos I; Westers TM; Stam AG; de Gruijl TD; Scheper RJ; Ossenkoppele GJ; van de Loosdrecht AA
Cancer Immunol Immunother; 2003 Jul; 52(7):455-62. PubMed ID: 12690520
[TBL] [Abstract][Full Text] [Related]
40. [Study on the anti-maturation features of immature dendritic cells induced by low dose of granulocyte macrophage colony stimulating factor].
Wang Q; Peng YZ
Zhonghua Shao Shang Za Zhi; 2004 Dec; 20(6):327-9. PubMed ID: 15730675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]